Price $14.53 |
Market Cap
16.39B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.77
|
P/S
0.95
|
Dividend %
3.30%
|
|
P/CF
96.2
|
P/FCF
8.2
|
Op. Cash Flow
2.53M
|
FCF
1.6
|
|
Op. Margin
-4.90%
|
Net Margin
-11.20%
|
ROE
-8.90%
|
ROI
-0.40%
|
|
ROA
-3.30%
|
EPS Growth
-469.50%
|
Current Ratio
1.2
|
Debt/Equity
97.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Generex Biotechnology Corporat (GNBT) | $0.05 | - | - | 7.6M | Strong Buy |
| Biomerica, Inc. (BMRA) | $4.37 | - | - | 48.8M | Strong Buy |
| Puma Biotechnology Inc (PBYI) | $2.40 | - | - | 130M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $63.54 | - | 3.50% | 138.77B | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.19 | - | - | 6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
